Companion to the [[cu-resin-swarm-incentive-screen]] alignment overlay and the three full swarm bundles. The three tickers are not peers in the GICS sense — they sit at three distinct layers of the AI-server substrate stack. The showdown question is which one deserves capital today given cur…
Companion to the [[cu-resin-swarm-incentive-screen]] alignment overlay and the three full swarm bundles. The three tickers are not peers in the GICS sense — they sit at three distinct layers of the AI-server substrate stack. The showdown question is which one deserves capital today given current price.
Live snapshot (yfinance, 2026-05-12 close):
| 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku | |
|---|---|---|---|
| Price | ¥11,190 | ¥16,550 | ¥50,850 |
| 1-year return | +340% | +570% | +1,181% |
| YTD return | +116% | +132% | +175% |
| 52w high / low | 11,780 / 2,385 | 18,365 / 2,426 | 53,200 / 4,030 |
| Market cap | ¥204B (~$1.3B) | ¥4.6T (~$30B) | ¥2.9T (~$19B) |
| Enterprise value | ¥200B | ¥4.3T | ¥3.0T |
SA mirror cross-check: Multiple SA pieces touch the AI-substrate stack (GB200 component teardown 2024, Blackwell rework 2024, Vera Rubin GTC 2025, advanced packaging 2022). Each deep-dive cross-checked SA — no contradictions surfaced. SA classifies 5706 as “bottleneck tier” in the AI-server PCB primer mirror.
| Metric | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Company | MEC Company Ltd. | Ibiden Co., Ltd. | Mitsui Kinzoku |
| Sector / Industry | Specialty Chemicals — PCB/substrate adhesion | Electronic Components — IC substrate | Diversified Metals — Cu foil + smelting |
| Stack position | Chemistry into PCB/substrate (CZ copper microetchant) | IC substrate fabricator (ABF FCBGA) | Cu foil into CCL (MicroThin + VSP) |
| Market cap | ¥204B | ¥4.6T | ¥2.9T |
| 52w performance | +369% | +582% | +1,162% |
| YTD performance | +116% | +132% | +175% |
| Div yield | 0.9% | 0.26% | 0.47% |
| Beta | 1.06 | 1.56 | 1.37 |
| 50d MA / Price | ¥7,832 / ¥11,190 | ¥9,901 / ¥16,550 | ¥35,550 / ¥50,850 |
| 200d MA / Price | ¥5,333 / ¥11,190 (+110%) | ¥6,841 / ¥16,550 (+142%) | ¥20,837 / ¥50,850 (+144%) |
| Analyst mean PT | ¥8,900 (-20% vs spot) | ¥10,441 (-37% vs spot) | ¥41,567 (-18% vs spot) |
| Analyst high PT | ¥10,000 (-11%) | ¥18,400 (+11%) | ¥56,700 (+12%) |
| # analysts | 2 (thin) | 17 | 9 |
All three: spot above analyst mean PT. Sell-side hasn’t caught up. The question is whose spot is the cleanest mispricing — and for which one will revisions catch up vs roll over.
| Dimension | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Revenue model | Specialty chemistry — sold per litre/kg into PCB and substrate fabs | Engineered substrates — sold per panel to packagers (Intel, AMD, Nvidia) | Cu foil + smelting — sold per roll to CCL makers + per tonne to industrial users |
| Revenue segments | Chemicals (CZ + AP + auxiliary) ~95%+; equipment 5% | Electronics ~75% (substrates), Ceramics ~20%, Other ~5% | Engineered Materials ~35% (Cu foil ~14% of group), Metals ~41% (smelting), Mobility ~20% (exiting), Other |
| Customer concentration | Diversified — sold to substrate fabs (Ibiden, Unimicron, Kinsus, AT&S, etc.); single largest <15% | Concentrated — Intel + Nvidia + AMD = >60% of substrate revenue; top-1 Intel ~30% | Estimated top-1 (Ibiden) 12-18%; top-3 30-40%; broader CCL base than 4062 |
| Competitive moat | Process / spec moat — 20yr ~100% PC CPU substrate share on CZ chemistry; CZ-8101 qualified into CoWoS chiplet packaging | Process / scale moat — 35yr ABF substrate franchise; Oono phase 2 capex contrarian bet locks high-end capacity | Process / spec moat — >90% global share in premium-grade circuit Cu foil (MicroThin carrier foil + VSP) |
| Moat strength | Strong within high-end CZ (alternatives can’t hit the roughness/adhesion spec) | Strong at flagship-tier ABF substrate; weakening if glass-core transitions by 2030 | Strong at premium grades; Korean/Chinese H-VLP3 catching up is the medium-term threat |
| TAM & penetration | Small TAM (~$2-3B specialty PCB chemistry) but high penetration | Mid TAM (~$15-20B ABF substrate + ceramic packages) with #1 share | Medium TAM (~$8-10B premium Cu foil) with >90% share at the top tier |
| Secular tailwinds | AI-PCB layer-count expansion; more-treatment-per-layer; CZ-8101 into CoWoS | AI accelerator substrate area scaling (3,025→8,100mm²); FY27 EPS growth from Oono | AI-server ABF substrate growth = Cu foil per substrate area; MicroThin USD +12% (Apr 2026); FY27 ROIC 27→49% |
Business model takeaway: - Most durable moat: 4971 — the smallest TAM but 100% share at the most spec-sensitive node. CZ is the “Intel Inside” of substrate chemistry. - Largest runway for growth: 5706 — single-product (Cu foil) growth into a structurally undersupplied market, layered onto a wrapper that the market still prices like a smelter. - Most market-cap-leveraged to AI: 4062 — already the largest of the three (¥4.6T) and the most directly tied to Nvidia substrate ramps. - Red flag scan: none of the three is structurally broken. The Mobility exit at 5706 is mgmt-engineered (disposing low-margin auto-parts) not crisis-driven.
| Metric | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Revenue (TTM) | ¥12.0B | ¥415B | ¥729B |
| Revenue growth (YoY) | +87.7% | +18.6% | +0.1% (group flat; Cu foil +50%+) |
| Gross margin | 61.6% | 31.6% | 22.9% |
| Operating margin | 27.4% (FY25E) / 15.4% (TTM) | 14.1% | 17.9% |
| Net margin | 14.5% | 15.3% | 8.5% |
| ROE | 12.8% | 12.2% | 18.4% |
| ROA | 7.9% | 3.6% | 8.7% |
| Metric | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Operating cash flow | n/a (yfinance gap) | ¥106B | n/a (yfinance gap) |
| Free cash flow | n/a (yfinance gap) | −¥47.5B (capex peak) | n/a (yfinance gap) |
| Total cash | ¥4.6B | ¥296B | ¥43B |
| Total debt | ¥1.25B | ¥193B | ¥136B |
| Net cash / (debt) | +¥3.4B (net cash) | +¥103B (net cash) | −¥93B (net debt; ND/EBITDA ~1.0x per deep-dive) |
| Shares out | 18.3M | 279M | 57.2M |
Financial health ranking: 1. 4971 MEC — net cash, 62% GM, no FX exposure ex-USD pass-through. Cleanest balance sheet. 2. 4062 Ibiden — net cash but capex peak driving negative FCF; through-cycle financial health A. 3. 5706 Mitsui Kinzoku — modest leverage (ND/EBITDA 1.0x) but ROIC 11% and rising. Conglomerate cash conversion clouded by zinc/lead working capital.
| Metric | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Revenue growth TTM | +88% | +19% | +0.1% (group) / +50%+ (Cu foil) |
| Earnings growth TTM | -17% (Y/Y comparison includes 2025 SBC-loaded) / FY25E EPS +90% per deep-dive | +247% | +99% |
| 3Y rev CAGR forward (per deep-dives) | ~20-25% (CZ-8101 ramp) | ~25-30% (Oono phase 2) | ~10-15% (Cu foil-led) |
| FY27 plan vs trajectory | Running ahead — Phase 2 OPM 28% vs ≥20% target; ROE 15% vs ≥10% | Running ahead — multi-year targets exceeded | Running far ahead — Feb 2026 raise already hits FY27 OI target a year early |
Growth drivers — by stock:
4971 MEC (0-24mo): 1. Kitakyushu plant Dec-2026 start adds ~30% capacity at the high-end 2. Suzhou +30% expansion by Dec-2026 3. CZ-8101 qualified into CoWoS chiplet packaging — secular AI exposure
4062 Ibiden (0-24mo): 1. Oono Phase 2 commissioning unlocks FY3/26 +34% rev consensus 2. Vera Rubin substrate supplier disclosure (H2 2026) 3. Q2 FY3/26 earnings (Jul-Aug 2026) — most consequential print
5706 Mitsui Kinzoku (0-24mo): 1. FY2025 full-year print TOMORROW May 13 + FY26 initial guide (binary catalyst) 2. 12% USD MicroThin price hike eff April 20 2026 — pricing power test 3. CEO transition April 1 2026 — Ikenobu Seiji (Cu-foil insider) takes over
Growth ranking: 1. 5706 — highest absolute growth in the Cu foil segment (foil ROIC 27→49% by FY30 per mgmt plan); but consolidated number gets diluted by smelting 2. 4062 — fastest forward EPS growth (consensus revisions still catching up post May print) 3. 4971 — smallest base, highest GM, but limited capacity to run faster than capex allows
| Multiple | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| P/E (TTM) | 41.1x | 77.2x | 62.4x |
| P/E (NTM) | 57.7x | 53.6x | 84.5x |
| EV/EBITDA (TTM) | 69.6x | 34.4x | n/a |
| EV/Revenue (TTM) | 16.7x | 10.3x | 4.2x |
| P/B | 14.7x | 8.5x | 8.0x |
| Stock | TTM P/E | 5Y avg P/E | Premium | Justified? |
|---|---|---|---|---|
| 4971 | 41x | ~22x | +86% | Partially — 28% OPM trajectory and FY27 sandbagging, but stretched |
| 4062 | 77x | ~25-30x (cyclical) | +150%+ | No — even bull-case FY3/27 EPS at 50x is below spot |
| 5706 | 62x | ~12-15x (smelter) | +300%+ | Yes — if you SOP the Cu foil sub at specialty-chem multiples (18-25x EV/EBIT) |
| Stock | DCF / SOP fair value range | Spot | Implied upside |
|---|---|---|---|
| 4971 | ¥6,500-9,000 | ¥11,190 | -20% to -42% to fair value |
| 4062 | ¥11,000-15,000 (DCF); ¥15,103 prob-weighted target | ¥16,550 | -9% to fair value (symmetric, modestly bear) |
| 5706 | ¥34,000 (SOP base, FY30 discounted to today); ¥63,000 (12M target) | ¥50,850 | +24% to 12M base case (with binary Q4 print as gating event) |
| Metric | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| ROIC | ~25-30% (per deep-dive) | ~10-12% (segment ~25%) | 27% (Cu foil); 11% (consolidated) |
| ROE | 12.8% | 12.2% | 18.4% |
| Insider ownership | 18.5% (incl. CEO 4%) | <2% (typical JP) | 4.1% |
| Recent insider activity | Neutral; SBC ~0.18% | Neutral | Neutral |
| Buyback yield TTM | Modest (¥1.29B FY25 + cancel 500k Aug 2025) | Inadequate (¥641M at FY3/25 trough when ¥50-100B was right) | Steady; dividend policy preferred over buyback |
| Dividend growth | 35%+ payout + 4%+ DoE (upgraded mid-MTP) | Standard JP payout | 35%+ payout + 3.5%+ DoE; FY25 DPS ¥240 (raised) |
| Capital allocation grade | A (deep-dive) | B+ (mgmt-dd) | A- (mgmt-dd) |
| Risk Dimension | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Cyclicality | Moderate | High (substrate cycle) | High (zinc/lead + Cu foil cycle) |
| Customer concentration | Low (diversified) | High (Intel + Nvidia + AMD >60%) | Moderate (top-3 30-40%) |
| Regulatory | Low | Low | Moderate (smelter environmental, Atalaya feasibility) |
| Leverage | Negligible | Low (net cash) | Moderate (ND/EBITDA 1.0x) |
| Key-person | High (CEO 24yr / no named #2) | Low | Low (succession formalized) |
| Competitive disruption | Medium (AP-series no-roughening for Gen-N+ is next platform) | Medium-High (glass-core 2030 transition) | Medium (Korean/Chinese H-VLP3 catch-up) |
| Macro sensitivity | Medium (USD pass-through; PCB cycle) | High (substrate cycle, China FX) | High (LME zinc/lead, yen) |
| Valuation | High (41x TTM vs 22x norm; sell-side -20%) | High (77x TTM; sell-side -37%) | High (62x TTM; sell-side -18%) |
| Technical Dimension | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|
| Trend (50d vs 200d MA) | Above both | Above both | Above both |
| RSI (14d, per deep-dives) | ~73 (overbought) | ~70 (overbought) | ~75+ (overbought) |
| % from 52w high | -5% | -10% | -4% |
| % above 200dMA | +110% | +142% | +144% |
| Recent volume trend | Accumulation Q1 26 → distribution warning at 52w high | Accumulation post Q1 print | Heavy accumulation Feb-Apr 2026 |
| Near-term setup | Unfavorable | Unfavorable | Binary (tomorrow’s print) |
Technical verdict: All three are stretched. None should be chased into the print. 5706 is the only one with a near-term catalyst that can resolve the technical extension either way. 4971 and 4062 need cooling-off (a 15-25% pullback) before a clean entry exists.
| Dimension | Weight | 4971 MEC | 4062 Ibiden | 5706 Mitsui Kinzoku |
|---|---|---|---|---|
| Business Quality | 20% | 5/5 | 4/5 | 5/5 |
| Financial Health | 15% | 5/5 | 4/5 | 3.5/5 |
| Growth | 20% | 3.5/5 | 4.5/5 | 4.5/5 |
| Valuation | 20% | 2/5 | 2.5/5 | 3.5/5 |
| Quality & Capital Allocation | 10% | 5/5 | 3.5/5 | 4.5/5 |
| Risk (inverted, lower=better=higher score) | 10% | 3.5/5 | 3/5 | 2.5/5 |
| Technical Timing | 5% | 2/5 | 2/5 | 2.5/5 |
| Weighted score | 100% | 3.65 | 3.50 | 3.80 |
| Rank | Ticker | Score | Verdict | One-line rationale |
|---|---|---|---|---|
| 1 | 5706 Mitsui Kinzoku | 3.80 | WATCH → BUY pending FY26 guide ≥¥130B OI | Only stock where SOP fair value > spot; binary catalyst tomorrow can resolve the trade |
| 2 | 4971 MEC | 3.65 | WATCH at ¥7-9k re-entry | Highest quality + cleanest balance sheet; spot is 20-42% above DCF |
| 3 | 4062 Ibiden | 3.50 | WATCH at ¥14-14.5k or post sell-side PT revision | Quality franchise but symmetric risk/reward; consensus catch-up trade either re-rates or unwinds |
5706 Mitsui Kinzoku — but after the May 13 FY26 initial guide, not before. The other two are quality businesses at the wrong price; 5706 is a quality business with a visible mispricing path (sum-of-parts-into-specialty-chem multiple) that no amount of waiting will necessarily fix on its own. The print is the gate. Guide ≥¥130B OI → tranche 1 (50% of intended position) at ¥45-48k. Guide <¥120B OI → walk away, revisit after a ¥35-40k sector drawdown.
Skip the diversification frame. These three are positively correlated (same AI-substrate macro factor). Owning all three is one trade with extra slippage. Pick one and size it; or wait for one to crack and pick the best of the survivors. The cleanest combination would be 5706 (post-print, mispricing thesis) + a 4971 starter at ¥7-9k (quality compounder ballast) — that combination separates the thesis trade from the quality compounder. Skip 4062 unless sell-side targets revise into the JPY 18-22k range, at which point the consensus-catch-up trade is over and the franchise stands on its own.
Pre-delivery checklist: - Redundancy sweep: references deep-dive material rather than duplicating; tables consolidate, do not repeat - Word justification: each table earns space — composite scorecard is the load-bearing synthesis - Register D pass: declarative, no hedge phrases, position-taking; “Pick one and size it” is the verdict